When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - FDA accepts Alexion's marketing application for expanded use of Soliris
Alexion Pharmaceuticals Inc.
The FDA accepts under Priority Review Alexion Pharmaceuticals' (ALXN+1%) supplemental marketing application seeking approval to use Soliris (eculizumab) to treat patients with neuromyelitis optica spectrum disorder (NMOSD) who have anti-aquaporin-4 (AQP4) autoantibodies (antibodies directed against the person's own proteins).
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news,